How will Precision BioSciences' stock react to PBGENE-HBV trial results? | Categorical | | | 2 months ago | |
Will PBGENE-HBV trial meet its primary endpoint by end of 2025? | Binary | | | 2 months ago | |
Will Moldova report adverse effects from PBGENE-HBV trial by end of 2024? | Binary | | | 2 months ago | |
Will PBGENE-HBV trial expand to other countries by mid-2025? | Binary | | | 2 months ago | |
What will be the outcome of the first phase of PBGENE-HBV trial by end of 2025? | Categorical | | | 2 months ago | |
What will be the EU's decision on PBGENE-HBV further trials by end of 2025? | Categorical | | | 2 months ago | |
Will Precision BioSciences' PBGENE-HBV trial complete Phase 1 by end of 2025? | Binary | | | 2 months ago | |
Will Moldova approve gene editing trials for other diseases by end of 2025? | Binary | | | 2 months ago | |
Will PBGENE-HBV trial show significant HBV DNA reduction by end of 2025? | Binary | | | 2 months ago | |
What will be the outcome of PBGENE-HBV trial's primary endpoint by end of 2025? | Categorical | | | 2 months ago | |
How many patients will be enrolled in PBGENE-HBV trial by end of 2025? | Categorical | | | 2 months ago | |
Which country will approve PBGENE-HBV trial next by end of 2025? | Categorical | | | 2 months ago | |
